Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishwajith Sridharan

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Hematology/Oncology Clinics of North America|November 1, 2019
Immunotherapy and Radiation: Charting a Path Forward TogetherVishwajith Sridharan, Jonathan D Schoenfeld
Discovery Medicine|April 2, 2015
Immune effects of targeted radiation therapy for cancerVishwajith Sridharan, Jonathan D Schoenfeld
Biochemistry|December 25, 2015
Regulation of Ras Paralog Thermostability by Networks of Buried Ionizable GroupsDaniel G Isom, Vishwajith Sridharan, Henrik G Dohlman
Molecular Cell|August 20, 2013
Protons as second messenger regulators of G protein signalingDaniel G Isom, Vishwajith Sridharan, Rachael Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
Merkel Cell Carcinoma: A Population Analysis on SurvivalVishwajith Sridharan, Vinayak Muralidhar, Danielle N Margalit, et al.
World Neurosurgery|May 26, 2015
Multicentric Low-Grade GliomasVishwajith Sridharan, Laura M Urbanski, Wenya Linda Bi, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patientsVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.
Oral Oncology|September 18, 2018
Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinomaVishwajith Sridharan, Rifaquat M Rahman, Raymond Y Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune SignaturesVishwajith Sridharan, Azfar Neyaz, Abhijit Chogule, et al.
Cancer Biomarkers : Section a of Disease Markers|April 8, 2017
Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinomaGlenn J Hanna, Vishwajith Sridharan, Danielle N Margalit, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|November 1, 2019
Immunotherapy and Radiation: Charting a Path Forward TogetherVishwajith Sridharan, Jonathan D Schoenfeld
Discovery Medicine|April 2, 2015
Immune effects of targeted radiation therapy for cancerVishwajith Sridharan, Jonathan D Schoenfeld
Biochemistry|December 25, 2015
Regulation of Ras Paralog Thermostability by Networks of Buried Ionizable GroupsDaniel G Isom, Vishwajith Sridharan, Henrik G Dohlman
Molecular Cell|August 20, 2013
Protons as second messenger regulators of G protein signalingDaniel G Isom, Vishwajith Sridharan, Rachael Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
Merkel Cell Carcinoma: A Population Analysis on SurvivalVishwajith Sridharan, Vinayak Muralidhar, Danielle N Margalit, et al.
World Neurosurgery|May 26, 2015
Multicentric Low-Grade GliomasVishwajith Sridharan, Laura M Urbanski, Wenya Linda Bi, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patientsVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.
Oral Oncology|September 18, 2018
Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinomaVishwajith Sridharan, Rifaquat M Rahman, Raymond Y Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune SignaturesVishwajith Sridharan, Azfar Neyaz, Abhijit Chogule, et al.
Cancer Biomarkers : Section a of Disease Markers|April 8, 2017
Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinomaGlenn J Hanna, Vishwajith Sridharan, Danielle N Margalit, et al.
Pageof 2